The value of biomarkers as diagnostic tool in Obstructive Sleep Apnea

The value of biomarkers as diagnostic tool in Obstructive Sleep Apnea - BiOSA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON49507

Enrollment

400

Registered

2020-05-14

Start date

2020-11-16

Completion date

Unknown

Last updated

2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleepapnea stop breathing

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - 18 years and older - Diagnosed with OSA confirmed by a PSG (AHI*30 events per hour)

Exclusion criteria

Exclusion criteria: - Central sleep apnea syndrome (>50% of central apneas) - Inability to provide informed consent

Design outcomes

Primary

Measure	Time frame
Changes in the selected biomarkers before and after OSA treatment.	—

Secondary

Measure	Time frame
Changes in AHI and subjective outcomes correlated to changes in biomarkers.	—

Countries

Netherlands

Outcome results